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A B S T R A C T
Atrioventricular block (AVB) in individuals with cardiac sarcoidosis (CS) is one of the major
complications caused by inﬂammation of the conducting system of the heart, as a sign of worse
prognosis. We report the case of a 53-year-old Japanese woman whose electrocardiogram showed
complete AVB by the clinical diagnosis of CS. We administered intravenous methylpredonisolone (1 g/
day) for 3 days. On the second day of steroid pulse therapy, the complete AVB improved to sinus rhythm
of 1st degree AVB and complete right bundle branch block. Normal sinus rhythm was then observed after
oral steroid therapy. These results suggest that in cases of complete AVB, steroid pulse therapy with a
strong anti-inﬂammatory effect may be recommended ﬁrst.
<Learning objective: This case illustrates a typical case of CS with complete AVB, but the cardiac
contraction was normal. In this setting, steroid pulse therapy may be effective when (1) the active
inﬂammation of the conduction system can be suppressed by steroid pulse therapy; (2) the time to start
steroid therapy is short enough to recover.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Atrioventricular block (AVB), a common complication of cardiac
sarcoidosis (CS), is caused by inﬂammation of the conducting system
of the heart. AVB is a sign of worse prognosis, and thus its early
diagnosis and treatment are important. There have been some
reports of CS patients in which atrioventricular (AV) conduction
disturbances were improved by steroid therapy [1]. However, there
have been few reports of patients with CS who underwent steroid
pulse therapy for AVB. We report herein the case of a patient with CS
whose complete AVB was completely recovered by intravenous
steroid pulse therapy followed by oral steroid treatment.
Case report
A 53-year-old Japanese woman was admitted to our hospital
with exertional shortness of breath and dizziness that had begun* Corresponding author at: Division of Cardiovascular Medicine, Department of
Medicine, Jichi Medical University School of Medicine, 3311-1 Shimotsuke, Tochigi,
Japan. Tel.: +81 285 58 7344; fax: +81 285 44 5317.
E-mail address: ke112@jichi.ac.jp (K. Eguchi).
http://dx.doi.org/10.1016/j.jccase.2015.09.003
1878-5409/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsone month earlier. She had no history of cardiovascular disease. On
physical examination, the Cannon sound was audible on the chest.
An electrocardiogram (ECG) showed complete AVB with an
escaped rhythm of the left bundle branch block type (Fig. 1A).
The left ventricular ejection fraction (LVEF) on echocardiography
was 66% with no abnormality in the size of the heart.
Interventricular septum was thickened to 13 mm without
morphological changes. Chest X-ray showed no cardiomegaly or
hilar lymph-adenopathy. The patient’s plasma brain natriuretic
peptide level was elevated (174.3 pg/mL), but other laboratory
tests such as serum calcium and angiotensin-converting enzyme
were within normal range. Cardiac magnetic resonance imaging
(CMR) demonstrated late gadolinium enhancement (LGE) at
the anteroseptal and lateral walls of the left ventricle (LV)
(Fig. 2).
T2-weighted CMR showed high-intensity signal areas at the
anteroseptal wall of the LV (Fig. 1D). 67Gallium imaging and 18F-
ﬂuorodeoxyglucose positron emission tomography (18F-FDG PET),
performed under long-fasting state >18 h [2], showed increased
uptake in the lateral and anteroseptal wall of the LV and in the hilar
and mediastinum lymph nodes (Fig. 2). Endomyocardial biopsy
was performed from the right ventricle, but typical non-caseating
granulomatous changes were not detected. reserved.
Fig. 1.
The electrocardiogram (ECG) of the patient, a 53-year-old woman, showed complete atrioventricular block (AVB) with escape beats of the left bundle branch
block type (A). ECG showed 18AVB with complete right bundle branch block on the second day of steroid pulse therapy (B). ECG, after 2 months of oral steroid
therapy, showed normal sinus rhythm (C).
Fig. 2.
T2-weighted cardiac magnetic resonance (CMR) showed high-intensity signal areas and wall thickening at anteroseptal wall of the left ventricle (arrow) (A). CMR
imaging demonstrated late gadolinium enhancement at the anteroseptal and lateral walls of the left ventricle (arrow) (B). 18F-ﬂuorodeoxyglucose positron
emission tomography images demonstrating abnormal uptake in the hilar lymph nodes and the anterior and inferior wall of the left ventricle (C), horizontal
plane, the interventricular septum and the lateral wall of the left ventricle (D).
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conﬁrmed the clinical diagnosis of systemic and cardiac sarcoido-
sis [3]. Expecting a strong anti-inﬂammatory effect and fewer
adverse effects, we administered intravenous methylpredoniso-
lone (1 g/day) for 3 days. On the second day, the ECG revealed a
change to 18AVB with complete right bundle branch block (CRBBB)
(Fig. 1B). We then started the patient on oral prednisolone
treatment (30 mg/day). The dose was tapered by 5 mg per 4-week
interval, and then maintained at the dose of 8 mg/day. One month
after the initiation of steroid therapy, the focal uptakes of 18F-FDG
PET presented in the anteroseptal and lateral wall of the left
ventricle were diminished. Two months later, the ECG normalized
to sinus rhythm without QRS abnormality (Fig. 1C). Prednisolone
was maintained as a dose of 8 mg/day, and no recurrence of the AV
conduction disturbances was observed 1 year later.
Discussion
We presented the case of a patient with cardiac sarcoidosis
whose complete AV block was completely recovered to 18AVB with
CRBBB by intravenous steroid pulse therapy, and then to normal
sinus rhythm on oral steroid treatment. Three possible mecha-
nisms may be involved in the remission of the complete AVB in this
case of CS. The ﬁrst mechanism is that the active inﬂammation in
the LV anteroseptal wall, running through the electrical conduc-
tion system, was suppressed by intravenous steroid therapy,
because the uptake of 18F-FDG PET disappeared in the LV
anteroseptal wall on steroid therapy. The efﬁcacy of per-oral
steroid therapy in CS was reported: 57.1% [4] and 63% [5] of cases
treated with this therapy returned to sinus rhythm.
The second possible mechanism is the use of a high dose of
steroid as an intravenous pulse therapy. We expected a strong anti-
inﬂammatory effect and faster expression by this regimen
compared to the oral administration of a steroid. In a study that
evaluated the long-term prognoses of CS by the initial dose
difference of steroid, there were no signiﬁcant differences in the
long-term prognosis between the low-dose group (prednisolone
30 mg/day) and the high-dose group (prednisolone 40 mg/day)
[6]. However, it has also been reported that high-dose predniso-
lone or intravenous steroid pulse therapy was effective in CS [7]. To
our knowledge, there has been no report of a CS case in which
intravenous steroid pulse therapy was performed from theFig. 3.
CMR imaging demonstrated late gadolinium enhancement at anterolateral w
month after the steroid pulse therapy (arrow) (B).beginning, as in the present case. We believe that only a high
dose of steroid can promptly suppress the active inﬂammation that
contributes to the manifestation of complete AVB.
The third candidate mechanism involves the timing of the
initiation of steroid treatment. Because the present patient’s
estimated duration of complete AVB was only 2 months, it was
short enough to recover to sinus rhythm. Kato et al. proposed that
the shorter the time to start steroid treatment from the onset of
AVB in CS, the greater the chance of improvement of the AV
conduction disturbance by steroid therapy [8]. In the present case,
the time to start steroid treatment from the onset of AVB was <6
months. These mechanisms together could have contributed to the
dramatic improvement in our patient’s AVB.
Steroid pulse therapy has been reported to have fewer side
effects compared to oral steroid therapy in general [9]. Regarding
the possible side effects of steroid pulse therapy, a susceptibility to
infection and edema has been noted, but even such adverse effects
can be easily managed as steroid pulse therapy is performed under
hospitalization.
If the anti-inﬂammatory effect of steroid treatment is attenu-
ated and the inﬂammation of sarcoidosis itself is reactivated, there
is a risk of the relapse of complete AVB. However, it is possible to
manage this by the early detection of symptoms under frequent
follow-up in an outpatient clinic. The risk of wound infection could
be increased when a pacemaker implantation is performed.
However, low-dose steroid treatment does not always increase
the operative risk [10]. We thus believe that a pacemaker
implantation even under steroid therapy does not always increase
the risk of adverse effects.
Complete AVB is a condition that can be a cause of sudden
cardiac death, and it is thus sometimes necessary to implant a
permanent pacemaker to prevent sudden cardiac death. When a
magnetic resonance imaging (MRI)-conditional pacemaker is
implanted, it is possible to follow the activity of the CS using
MRI [11]. However, this method provides only a limited assess-
ment of the quality of the myocardium, because of the artifacts due
to pacemaker leads. Orii et al. recently reported that the
improvement in the inﬂammation can be sensitively assessed by
FDG-PET rather than by using the LGE on cardiac MRI in CS patients
with complete AVB [12]. In the present patient’s case, we obtained
CMR images before and at 2 months after the steroid pulse therapy
(Fig. 3), but the LGE was not changed by the treatment. In the Oriiall of the left ventricle before the steroid pulse therapy (arrow) (A) and at the 2nd
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myocardial inﬂammation, and those authors reported that FDG-
PET was superior to CMR to predict the potential to improve
complete AVB when steroid therapy is being administered
[12]. We thus decided to use FDG-PET to follow up the disease
activity of our CS patient, and we observed that her FDG-PET
ﬁndings at 2 months and at 1 year after the completion of steroid
therapy had improved in accordance with her stable clinical
condition presenting as normal sinus rhythm.
In conclusion, we treated a CS patient whose complete AVB was
immediately improved by intravenous steroid pulse therapy. In
cases of CS with new-onset complete AVB, a short duration of
complete AVB and preserved LVEF could be major signs of
successful intravenous steroid pulse therapy.
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